NYU Langone Health is seeking a Director for the Solid Tumor Cell Therapy Program to lead growth and innovation in solid tumor immunotherapy across multiple disease subtypes and disciplines.
The role requires strategic leadership within the expanding cell therapy program, collaboration with clinical and research teams, and a track record in advancing translational immunotherapy programs.
#J-18808-LjbffrDirector, Solid Tumor Cell Therapy — Lead Immunotherapy Innovation in new york at Unknown Company
This position is listed as full time and onsite.